Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Global Experts Warn of Risks from Synthetic 'Mirror Bacteria'
Biotech & Bioprocessing Global Experts Warn of Risks from Synthetic 'Mirror Bacteria'

Imagine a world where synthetic organisms, known as mirror bacteria, thrive undetected due to their reversed molecular chirality, posing significant risks to human health and the environment. Researchers from diverse scientific fields, including immunology, ecology, and biosecurity, are raising

Building the Future: Why Biopharma Campuses Must Evolve
Editorial Building the Future: Why Biopharma Campuses Must Evolve

The life sciences industry has come a long way since the last COVID-19 outbreak. Today, organizations are prioritizing efficiency, speed, and innovation. That’s why biopharma and biotech companies are increasingly broadening their investments in physical spaces. Campuses and facilities are being

Can Programmable Nanomachines Revolutionize Drug Delivery Systems?
Tech & Innovation Can Programmable Nanomachines Revolutionize Drug Delivery Systems?

The field of nanotechnology is rapidly evolving, with significant advancements being made in the development of nanomachines—tiny biological devices capable of performing complex functions within living organisms. These innovations hold the potential to revolutionize various fields, particularly

New Genetic Insights Reveal Why Autism Is More Common in Males
Research & Development New Genetic Insights Reveal Why Autism Is More Common in Males

The prevalence of autism spectrum disorder (ASD) in males as opposed to females has baffled researchers for years, sparking a multitude of investigations aimed at uncovering the underlying genetic factors. Recent studies published in the American Journal of Human Genetics have unveiled

How is Mexico Leading the EHR Market with Digital Innovation?
Tech & Innovation How is Mexico Leading the EHR Market with Digital Innovation?

Mexico is at the forefront of a digital health revolution, particularly in the realm of Electronic Health Records (EHR). This rapid transformation is driven by a combination of government initiatives, regulatory changes, and a growing demand for modernized healthcare systems. The country’s

Is Gozetotide Plus Lutetium-177 Therapy a Breakthrough in Prostate Cancer?
Research & Development Is Gozetotide Plus Lutetium-177 Therapy a Breakthrough in Prostate Cancer?

The field of prostate cancer treatment has seen significant advances with the introduction of novel therapies aimed at enhancing patient outcomes. One such promising advancement is the use of gozetotide for the accurate detection of PSMA-positive prostate cancer. This breakthrough is particularly

Are Graphene and Nanotech in Dental Anesthetics a Hidden Danger?
Tech & Innovation Are Graphene and Nanotech in Dental Anesthetics a Hidden Danger?

The recent discovery of graphene oxide and nanotechnology in dental anesthetics has sparked significant concern among healthcare professionals and the public. This revelation, brought to light by various medical professionals and research groups, highlights the potential risks and ethical

Digital Health in 2024: Surprising Shifts, AI Growth, and New Challenges
Tech & Innovation Digital Health in 2024: Surprising Shifts, AI Growth, and New Challenges

The digital health landscape in 2024 has been marked by unexpected developments, rapid advancements, and new challenges. Industry executives have reflected on the year's most surprising and impactful occurrences, providing insights into the evolving dynamics of healthcare technology. This article

Debate Erupts as Pediatric Cancer Research Funds Cut from Spending Bill
Research & Development Debate Erupts as Pediatric Cancer Research Funds Cut from Spending Bill

Government Funding Bill Removes Pediatric Cancer Research Program In a surprising turn of events, the recent changes in the U.S. government's temporary funding bill have sparked controversy, as funding for pediatric cancer research has been excluded. The new bill, aimed at preventing a government

Are Stimulants the Best Treatment for ADHD in Adults?
Research & Development Are Stimulants the Best Treatment for ADHD in Adults?

Attention deficit-hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder that significantly impacts daily functioning and development. Characterized by persistent patterns of hyperactivity, impulsivity, and inattention, ADHD affects about 5% of children aged 6–18 years and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later